1 July 2000 in Computer Methods and Programs in Biomedicine
31 May 2012 in Journal of Telemedicine and Telecare
We studied whether preventive home monitoring of patients with chronic obstructive pulmonary disease (COPD) could reduce the frequency of hospital admissions and lower the cost of hospitalization. Patients were recruited from a health centre, general practitioner (GP) or the pulmonary hospital ward. They were randomized to usual care or tele-rehabilitation with a telehealth monitoring device installed in their home for four months. A total of 111 patients were suitable for inclusion and consented to be randomized: 60 patients were allocated to intervention and three were lost to follow-up. In the control group 51 patients were allocated to usual care and three patients were lost to follow-up. In the tele-rehabilitation group, the mean hospital admission rate was 0.49 per patient per 10 months compared to the control group rate of 1.17; this difference was significant ( P = 0.041). The mean cost of admissions was €3461 per patient in the intervention group and €4576 in the control group; this difference was not significant. The Kaplan-Meier estimates for time to hospital admission were longer for the intervention group than the controls, but the difference was not significant. Future work requires large-scale studies of prolonged home monitoring with more extended follow-up.
31 March 2014 in Journal of Diabetes Science and Technology
Background: Hypoglycemia is a common and serious side effect of insulin therapy in patients with diabetes. Early detection and prediction of hypoglycemia may improve treatment and avoidance of serious complications. Continuous glucose monitoring (CGM) has previously been used for detection of hypoglycemia, but with a modest accuracy. Therefore, our aim was to investigate whether a novel algorithm that adds information of the complex dynamic/pattern of heart rate variability (HRV) could improve the accuracy of hypoglycemia as detected by a CGM device. Methods: Data from 10 patients with type 1 diabetes studied during insulin-induced hypoglycemia were obtained. Blood glucose samples were used as reference. HRV patterns and CGM data were combined in a mathematical prediction algorithm. Detection of hypoglycemic periods, performed by the algorithm, was treated as a pattern recognition problem and features/patterns derived from HRV and CGM prior to each blood glucose sample were used to decide if that particular point in time was below the hypoglycemic threshold of 3.9 mmol/L. Results: A total of 903 samples were analyzed by the novel algorithm, which yielded a sensitivity of 79% and a specificity of 99%. The algorithm was able to detect 16/16 hypoglycemic events with no false positives and had a lead time of 22 minutes as compared to the CGM device. Conclusions: Detection accuracy and lead time were significantly improved by the novel algorithm compared to that of CGM alone.
14 October 2015 in Journal of Diabetes Science and Technology
Diabetes is one of the top priorities in medical science and health care management, and an abundance of data and information is available on these patients. Whether data stem from statistical models or complex pattern recognition models, they may be fused into predictive models that combine patient information and prognostic outcome results. Such knowledge could be used in clinical decision support, disease surveillance, and public health management to improve patient care. Our aim was to review the literature and give an introduction to predictive models in screening for and the management of prevalent short- and long-term complications in diabetes. Predictive models have been developed for management of diabetes and its complications, and the number of publications on such models has been growing over the past decade. Often multiple logistic or a similar linear regression is used for prediction model development, possibly owing to its transparent functionality. Ultimately, for prediction models to prove useful, they must demonstrate impact, namely, their use must generate better patient outcomes. Although extensive effort has been put in to building these predictive models, there is a remarkable scarcity of impact studies.
26 July 2018 in Journal of Diabetes Science and Technology
Introduction: Patients with diabetes often generate large amounts of data specifically related to the disease and to their general health. Cross-institutional sharing of patient health care data is complex, and as a consequence, data are not always available to the health care provider treating the patient. Accommodating this challenge could lead to better clinical effectiveness and improve clinical research. This work aims to present an approach for a blockchain-based platform for sharing health care data. The approach considers privacy concerns, data sharing, and patients as the center for governing their own data. Methods: The concept of this blockchain-based platform consists of using the NEM multi-signature blockchain contracts for access control of data management and the sharing and encryption of data to allow privacy and control of health care data. The architecture is built around cryptography, tokens, and multi-signature contracts. The multi-signature contract enables several entities to administrate the activity of an account and control the assets of one account. Multi-signature generates a contract that assigns the rights and powers of a certain account to other accounts; this contract can be edited to allow or remove entities. Discussion: Using blockchain could lead to improvements in diabetes data management. In the coming years, this technology should be implemented in existing small-scale diabetes health care system to explore its real-world benefits and challenges. Conclusion: This new approach could potentially lead to more efficient sharing of data between institutions and utilization of new types of data and research possibilities.
1 August 2017 in Respiratory Medicine